We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are…
Tag: Pharmaceuticals
GSK to buy liver disease drug from Boston Pharmaceuticals for up to $2 billion
GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm…
Accretion Pharmaceuticals IPO opens for subscription: Price band, GMP among key details to know
Accretion Pharmaceuticals has opened its initial public offering (IPO) for subscription today, May 14. The IPO, which is set to…